The FDA has approved a drug that they say slows the progression of Alzheimer’s. But it carries a high risk of brain swelling, severe headaches, strokes and “tiny bleeds.”
The drug is called lecanemab, sold under the brand name Leqembi. The drug maker said that people who took it in clinical trials “declined 27% more slowly.” So it does not cure Alzheimer’s. It slows it down but it could also be dangerous. The drug maker says that it is especially dangerous for people on blood thinners.
Would you take that risk?
The FDA wants to add this drug to Medicare programs so that the government will cover the $26,500-year drug.
